COST picto_medicine
BMBS
Members Area
 
Homepage
Domains and Actions
>BMBS
>Actions
>Meetings
>in Detail
>DC Members
>DC Rapporteurs
>DC BMBS Liaisons
Search Actions
GO TOP GO BOTTOM
CE EU
COST is supported by the EU RTD Framework Programme
 
GO BOTTOM GO BOTTOM
GO TOP GO BOTTOM
ESF
ESF provides the COST Office through a European Commission contract
 
GO BOTTOM GO BOTTOM
GO TOP GO BOTTOM
CE EU
The Council of the European Union provides the COST Secretariat
 
GO BOTTOM GO BOTTOM

Action B14: Hyperbaric Oxygen Therapy


 
Action overview

Printable version

The main objective was to improve the knowledge required for a rational use of HBOT, to a level making it possible to set out specific guidelines for the implementation and development of clinical HBOT centres and to provide scientifically sound recommendations for HBOT treatment of various diseases and conditions.

The main results of the COST Action B14 are :

In research: Consensus documents on methods and ethical aspects of clinical research in HBO;Implementation of a research network in Europe. The work done in this network attracted the participation of South Africa, Australia and Canada; 6 clinical randomised controlled studies going on in Europe

In education : Structuration of initial and continuous medical education in Europe has been achieved and a common syllabus for each level of education in hyperbaric medicine has been agreed; An European textbook has been published, reflecting the view and contribution of European teams;
In quality and safety of clinical care: A code of good practice has been elaborated and disseminated to every HBO centre in Europe; COST Action has been the initiator of the elaboration of an harmonized European norm (pr EN 14 931, prepared by the CEN TF 127)

In communication: A web site has been implemented (www.oxynet.org) and is used by the HBO community for its exchange.


Domain : Biomedicine and Molecular Biosciences
Action title : Hyperbaric Oxygen Therapy



Action details Parties
  Country Date Status
Draft MoU : 295/98
MoU : 320/98
CSO Approval date : 25/06/1998
Entry into force : 09/12/1998
End of Action : 08/12/2003
End of prolongation : 08/03/2005
Austria 09/12/1998 Confirmed
Belgium 09/12/1998 Confirmed
Cyprus 17/07/2001 Confirmed
Czech Republic 12/05/2000 Confirmed
Denmark 09/12/1998 Confirmed
Finland 09/06/1999 Confirmed
France 08/03/2000 Confirmed
Germany 09/12/1998 Confirmed
Greece 18/12/1998 Confirmed
Israel 13/11/2001 Confirmed
Italy 05/05/1999 Confirmed
Netherlands 10/02/1999 Confirmed
Poland 09/03/1999 Confirmed
Portugal 29/04/1999 Confirmed
Slovenia 09/12/1998 Confirmed
Spain 13/01/1999 Confirmed
Sweden 24/02/1999 Confirmed
Switzerland 09/12/1998 Confirmed
United Kingdom 09/12/1998 Confirmed
Total 19  
 
Intentions to accept the MoU
Country   Status
Total 0  


Action Web Site: http://www.oxynet.org

Notice board

More Information can be obtained through the website :
http://www.oxynet.org

or  by contacting the Chair of the Action :
Prof. Daniel MATHIEU

Science Officer :
Dr Magdalena RADWANSKA

Administrative Officer :
Ms Gabriela CRISTEA



Legal Notice | Accessibility | Sitemap top